Annual Drug Patent Expirations for REZZAYO
Rezzayo is a drug marketed by Cidara Theraps and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has seventy patent family members in twenty-four countries.
The generic ingredient in REZZAYO is rezafungin acetate. One supplier is listed for this compound. Additional details are available on the rezafungin acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com